LCM
TWST icon

Laurion Capital Management’s Twist Bioscience TWST Stock Holding History

Laurion Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-40,000
Closed -$924K – 1303
2018
Q4 		$924K Buy
+40,000
New +$886K 0.02% 576

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Laurion Capital Management's TWST Position: Q1 2019 in Review

Laurion Capital Management sold out of Twist Bioscience (TWST) in Q1 2019, closing a stake of 40,000 shares — an estimated $924K sold.

Laurion Capital Management first reported a position in TWST in Q4 2018 and held it in 1 quarter. The position peaked at $924K in Q4 2018. 49 funds tracked by Wall St. Rank hold TWST as of Q1 2019.

  • Laurion Capital Management reported no remaining Twist Bioscience position as of Q1 2019 after selling out during the quarter.
  • Laurion Capital Management sold 40,000 Twist Bioscience shares in Q1 2019, an estimated $924K.
  • Laurion Capital Management first reported a position in Twist Bioscience in Q4 2018 and held it in 1 quarter.
  • Laurion Capital Management's Twist Bioscience position peaked at $924K in Q4 2018.
  • 49 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2019.

Based on Laurion Capital Management's 13F filing for Q1 2019, filed 8 May 2019.